Novel antiviral agent tetraglycylated nordihydroguaiaretic acid hydrochloride as a host-dependent viral inhibitor

Antiviral Research

Volumn 58, Issue 1, 2003, Pages 57-64

  Huang, Ru Chih C ^a   Li, Yen ^b   Giza, Paul E ^a   Gnabre, John N ^a   Abd Elazem, Ibrahim S ^a   King, Ke Yung ^c,d   Hwu, Jih Ru ^c,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d INSTITUTE OF CHEMISTRY   (Taiwan)

Author keywords

G4N; Human immunodeficiency virus; Simian immunodeficiency virus; Sp1; Tetra O glycyl nordihydroguaiaretic acid

Indexed keywords

3' O METHYLNORDIHYDROGUAIARETIC ACID; ANTIVIRUS AGENT; CHLORIDE; DICYCLOHEXYLCARBODIIMIDE; DIMETHYLAMINOPYRIDINE; DIMETHYLGLYCINE; NORDIHYDROGUAIARETIC ACID; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PYRIDINE DERIVATIVE; RECOMBINANT PROTEIN; TETRAGLYCATED NORDIHYDROGUAIARETIC ACID; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; WATER;

ARTICLE; CELL CULTURE; CELL DIVISION; CHEMICAL REACTION; DNA BINDING; DRUG EFFECT; DRUG SYNTHESIS; GEL MOBILITY SHIFT ASSAY; GLYCATION; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REACTION ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; SOLUBILITY; TRANSACTIVATION; VIRUS INHIBITION;

ANIMALS; ANTI-HIV AGENTS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPATHOGENIC EFFECT, VIRAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; NORDIHYDROGUAIARETIC ACID; SIMIAN IMMUNODEFICIENCY VIRUS; SP1 TRANSCRIPTION FACTOR;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0242418170     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00189-4     Document Type: Article

References (22)

1. Abd-Elazem I.S., Chen H.S., Bates R.B., Huang R.C. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antivir. Res. 55:2002;91-106.
2. Chen H., Teng L., Li J.N., Park R., Mold D.E., Gnabre J.N., Hwu J.R., Tseng W.N., Huang R.C. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation-insensitive transcription inhibitor tetra-O-methyl-NDGA. J. Med. Chem. 41:1998;3001-3007.
3. Craigo J., Callaham M., Huang R.C., DeLucia A.L. Inhibition of human papilloma virus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives. Antivir. Res. 47:2000;19-28.
4. Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., Huang R.C. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. U.S.A. 92:1995a;11239-11243.
5. Gnabre J.N., Huang R.C., Bates R.B., Burns J.J., Caldera S., Malcomson M.E., McClure K.J. Characterization of anti-HIV lignans from Larrea tridentate. Tetrahedron. 51:1995b;12203-12210.
6. Gnabre J.N., Ito Y., Ma Y., Huang R.C. Isolation of anti-HIV-1 lignans from Larrea tridentate by counter-current chromatography. J. Chromatogr. A. 719:1996;353-364.
7. Heller, J.D., 2002. Discovery and Mechanism of the Anti-cancer Chemotherapeutic Tetra-O-methyl Nordihydroguaiaretic Acid. Ph.D. Thesis, Johns Hopkins University, UNI Dissertation Publishing.
8. 2 Arrest in Mammalian Cells and Exhibits Tumoricidal Activity In Vivo Cancer Research, vol. 61, pp. 5499-5504.
9. Huang, R.C., Heller, J.D., Hwu, J.R., King, K.Y., 2002. Nordihydroguaiaretic Derivatives for Use in Treatment of Tumors. U.S. Patent 6,417,234B1.
10. Hwu J.R., Tseng W.N., Gnabre J.N., Giza P.E., Huang R.C. Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification and inhibition of Tat-regulated HIV transactivation. J. Med. Chem. 41:1998;2994-3000.
11. King, K.Y., 2000. Design and Synthesis of New Silicon-Containing Poly(dienes) and Polyureas as Photo-degradable Polymers and Development of Lignan Derivatives as New Anti-HIV Agents. Ph.D. Thesis, National Tsing Hua University, Hsinchu, Taiwan, ROC.
12. King, K.Y., Hakimelahi, G.H., Huang, R.C., Hwu, J.R., in press. Design, Synthesis and Binding Studies of Highly Water Soluble Nordihydroguaiaretic Acide Derivatives. J. Genet. Mol. Biol.
13. Mewshaw J.P., Myrick F.T., Wakefield D.A., Hooper B.J., Harris J.L., McCreedy B., Borroto-Esoda K. Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails. J. Acquir. Immune Defic. Syndr. 29:2002;11-20.
14. 4N. Ph.D. Thesis, Johns Hopkins University, UMI Dissertation Publishing.
15. Park, R., Giza, P., Mold, D.E., Huang, R.C., in press. Inhibition of HSV-1 replication and reactivation by the mutation insensitive transcription inhibitor tetra-O-glycyl nordihydroguaiaretic acid. Antivir. Res.
16. Sjottem E., Anderson C., Johansen T. Structural and functional analyses of DNA bending induced by Sp1 family transcription factors. J. Mol. Biol. 267:1997;490-504.
17. Squires K.E. An introduction to nucleoside and nucleotide analogues. Antivir. Ther. 6(3):2001;1-14.
18. Tavel J.A. Ongoing trials in HIV protease inhibitors. Expert Opin. Investig. Drugs. 9:2000;917-928.
19. Uckun F.M., Narla R.K., Jun X., Zeren T., Venkatachalam T., Wadick K.G., Rostostev A., Myers D.E. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. Clin. Cancer Res. 4:1998;901-912.
20. Veronese F.D., Samgadharan M.G., Rahman R., Markham P.D., Popovic M., Bodner A.J., Gallo R.C. Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. Proc. Natl. Acad. Sci. U.S.A. 82:1985;5199-5202.
21. Weislow O.S., Kiser R., Fine D.L., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81:1989;557-586.
22. Yoshimura K., Kato R., Kavlick M.F., Nguyen A., Maroun V., Maeda K., Hussain K.A., Ghosh A.K., Gulnik S.V., Erickson J.W., Mitsuya H. A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TM-126), and selection of a novel (A28S) mutation in the protease active site. J. Virol. 76:2002;1349-1358.